Dr. Saul Frenkiel

Saul Frenkiel, MDCM, FRCS(C)

Education:

1971-Medical Degree MDCM McGill University

1976 - Specialty Training in Otolaryngology – Head and Neck Surgery, FRCS (C)

University of Toronto

1976 – Diplomat, American Board of Otolaryngology

Biography:

Dr. Saul Frenkiel is presently Professor of Otolaryngology - Head and Neck Surgery at McGill University. He previously served as Chairman of the University Department (2002-2014) and was the former Clinical Chief at the MUHC (2002-2014) and Jewish General Hospital (1992-2011).

Other previous significant positions include President of the Canadian Society of Otolaryngology - Head and Neck Surgery (2006-2007), Executive Committee member of the Association d’otorhinolaryngologie-cervicofaciale du Quebec (1991-1993), Associate Editor of the Journal of Otolaryngology - Head and Neck Surgery (1991-2004) and Royal College of Physicians and Surgeons of Canada Fellowship Examiner (1994-1998). He also served as International Representative to the American Academy of Otolaryngology-Head and Neck Surgery (2006-2010).

Dr. Frenkiel has been a frequent Visiting Professor to University training programs and has delivered numerous lectures to National and International Societies. He has been a Course Director for many workshops on endoscopic sinus surgery. He was also invited to be the Millennium Lecturer in Rhinology for the Canadian Society of Otolaryngology - Head and Neck Surgery (2000). He has over 150 publications, including textbook chapters, peer-reviewed and periodical articles, and multi-media works. He has also co-authored the Canadian National Guidelines on Rhinitis and Sinusitis.

Clinical Interests:

Dr. Frenkiel’s primary clinical interests are in the sub-specialty of rhinology and endoscopic sinus surgery.

Research:

His research activities have included work on the molecular biology of chronic sinusitis, mucociliary physiology, and nasal airflow testing. Other research has involved the newer technology of virtual sinuscopy. His current research is presently focused on the molecular pharmacology and genetics of cystic fibrosis.

Page last updated on 

We always seek feedback to make our site better.